Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 2Phase 2 2

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1

Conditions

Neoplasms 8Neoplasm Metastasis 8Carcinoma, Non-Small-Cell Lung 8Breast Neoplasms 8Colorectal Neoplasms 7Prostatic Neoplasms 6Urinary Bladder Neoplasms 5Leukemia, Myeloid, Acute 5Squamous Cell Carcinoma of Head and Neck 4Ovarian Neoplasms 4Lung Neoplasms 4Glioblastoma 4Triple Negative Breast Neoplasms 3Mouth Neoplasms 3Head and Neck Neoplasms 3Carcinoma, Transitional Cell 3Carcinoma, Ovarian Epithelial 3Uterine Cervical Neoplasms 2Ureteral Neoplasms 2Stomatitis 2Recurrence 2Oropharyngeal Neoplasms 2Melanoma 2Laryngeal Neoplasms 2Gastrointestinal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma 2COVID-19 2Brain Neoplasms 2Adenocarcinoma 2

Interventions

Cyclophosphamide 58Dexamethasone 50Rituximab 39Peripheral Blood Stem Cell Transplantation 29Paclitaxel 29Lenalidomide 28fludarabine phosphate 27Gemcitabine 26Etoposide 26Bortezomib 26Cytarabine 25Busulfan 24pembrolizumab 21Radiotherapy 21Bevacizumab 21Carboplatin 20Mycophenolic Acid 19Melphalan 19Cisplatin 19Filgrastim 18pomalidomide 17fludarabine 17Oxaliplatin 17Antilymphocyte Serum 17Cyclosporine 16Tacrolimus 15Methotrexate 15Whole-Body Irradiation 14Methylprednisolone 13Bendamustine Hydrochloride 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Recurrence × Standard of Care × Clear all
NCT05704829 2025-11-19

ADAPTHER2-IV

West German Study Group

Phase 2 Active not recruiting
402 enrolled

Recurrence

NCT02107378 2016-11-30

Efficacy of DCVAC/OvCa Plus Standard of Care in Relapsed Platinum Resistant Epithelial Ovarian Carcinoma

Sotio Biotech Inc.

Phase 2 Terminated
22 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡